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Human chromosome 10q21-22 harbors USH1F in a region of conserved synteny to mouse chromosome 10. This
region of mouse chromosome 10 contains Pcdh15, encoding a protocadherin gene that is mutated in ames waltzer
and causes deafness and vestibular dysfunction. Here we report two mutations of protocadherin 15 (PCDH15)
found in two families segregating Usher syndrome type 1F. A Northern blot probed with the PCDH15 cytoplasmic
domain showed expression in the retina, consistent with its pathogenetic role in the retinitis pigmentosa associated
with USH1F.
Introduction
Usher syndrome is estimated to be the most frequent
cause of deaf-blindness in the United States (Kimberling
et al. 1991). Usher syndrome type I (USH1) is the most
common of the three clinical subtypes (Astuto et al.
2000). It is characterized by congenital profound sen-
sorineural hearing loss, vestibular areflexia, and retinitis
pigmentosa, with onset near puberty (Smith et al. 1994).
Six loci (A–F) for USH1 are known (Kaplan et al. 1992;
Kimberling et al. 1992; Smith et al. 1992; Wayne et al.
1996, 1997; Chaib et al. 1997). Genes for three of these
loci have been identified: Usher syndrome type 1B
(USH1B [MIM 276903]; Weil et al. 1995), Usher syn-
drome type 1C (USH1C [MIM 276904]; Bitner-Glind-
zicz et al. 2000; Verpy et al. 2000), and Usher syndrome
type 1D (USH1D [MIM 601067]; Bolz et al. 2001; Bork
et al. 2001).
Usher syndrome type 1F (USH1F [MIM 602083])
was first reported by Wayne et al. (1997). The flanking
markers, D10S199 and D10S596 at 10q21-22, span
a 15-cM interval centromeric to DFNB12/USH1D
(Wayne et al. 1997).USH1D andUSH1F, both on chro-
mosome 10, are the second-most-common cause of
Usher syndrome, following mutations in myosin VIIa
(MYO7A or USH1B [MIM 276903]; Astuto et al.
2000). The frequency of Usher syndrome was estimated
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to be 3.5 in 100,000 individuals living in Scandinavia
(Hallgren 1959; Nuutila 1970; Grondahl 1987) and 4.4
in 100,000 individuals living in the United States
(Boughman et al. 1983). Of the three Usher syndromes,
type 1 is the most common in families of European
extraction. Among families with USH1, mutations in
MYO7A (USH1B) account for 140% of incidences of
deaf-blindness (Liu et al. 1998b; Friedman et al. 1999;
Astuto et al. 2000). In our sampling of 120 families,
ascertained in Pakistan, who have inherited profound,
congenital deafness (Friedman et al. 2000), 8 families
showed linkage to USH1D/DFNB12 (Bork et al. 2001)
and 3 families showed linkage to USH1F/DFNB23.
Mutations in mouse orthologues of known Usher
genes are excellent animal models of this phenotype.
Mutations in MYO7A/Myo7a are found in patients
with DFNB2, USH1B, DFNA11, and in shaker-1 (sh1)
mice (Gibson et al. 1995; Weil et al. 1995; Liu et al.
1997a, 1997b; Weil et al. 1997). The phenotype of sh1
mice is characterized by hyperactivity, head tossing, and
circling behavior due to vestibular and cochlear dys-
function (Gibson et al. 1995). Moreover, it has recently
been shown that recessive mutations of cadherin 23
(CDH23 [MIM 605516]) are associated with nonsyn-
dromic deafness DFNB12 (Bork et al. 2001) and
USH1D (Bolz et al. 2001; Bork et al. 2001) and that
mutations of the mouse orthologue, Cdh23, are the
cause of the waltzer phenotype (Di Palma et al. 2001).
In the present study, we refined the map location of
USH1F to an interval of 1 Mb of DNA at 10q21.1.
Mutations in protocadherin 15 (PCDH15 [MIM
605514; GenBank accession number AY029237])—the
human orthologue of mouse Pcdh15, which is respon-
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sible for the Ames waltzer (av) phenotype (Alagramam
et al. 2001)—were found in two families with USH1F.
Subjects, Material, and Methods
Subjects, Sample Collection, and Genomic DNA
Isolation
Institutional review board approval (OH93-N-016)
and written informed consent were obtained for all sub-
jects in this study. Peripheral blood samples were ob-
tained from participating subjects. DNA was extracted
from peripheral blood (Grimberg et al. 1989) or from
buccal swabs (BuccalAmp DNA-extraction kit, Epi-
centre Technologies). Pure-tone audiometry, fundoscopy,
and electroretinogram (ERG) exams were performed on
selected affected individuals aged 113 years from each
family.
Linkage Analysis
DNA samples were PCR amplified with fluorescently
labeled primers surrounding microsatellite repeats at
known Usher syndrome and recessive deafness loci. PCR
products were visualized by gel electrophoresis on an
ABI 377 DNA sequencer, and genotypes were deter-
mined by Genescan and Genotyper (PE Biosystems). All
genetic distances herein are based on published data
(Broman et al. 1998). Additional primers in the USH1F
linkage region were end-labeled with [g-32P] through use
of T4 polynucleotide kinase. PCR products were sepa-
rated by electrophoresis on a 6% denaturing urea/poly-
acrylamide gel and were visualized by autoradiography.
LOD scores were calculated by FASTLINK (Schaffer
1996). The disease was coded as fully penetrant, and
the disease-allele frequency was set at .001. Meiotic re-
combination frequencies were assumed to be equal for
males and females. The allele frequencies of the simple-
tandem-repeat polymorphism (STRP) markers were
calculated by genotyping of 96 randomly selected un-
affected individuals from the same population.
Physical Mapping
A physical map of the refined linkage region was con-
structed through use of information from the Washing-
ton University Genome Sequencing Center FPC database
Web site and the Sanger Centre Web site (fig. 2A). Se-
quence homology searches of available BAC sequences
were performed, using the National Center for Biotech-
nology Information Web database and the Celera Hu-
man Genome Publication Web site, to find additional
sequence information. Sequence data were confirmed to
belong to the linkage interval through the discovery and
typing of additional STRPs found among BACs or of
sequences that pertained to the linkage region. Known
genes and expressed-sequence tags (ESTs) present in the
refined region were obtained by BLAST searches using
BLASTn, BLASTx, and tBLASTn (Zhang et al. 1998)
against the available “nt” and “nr” databases down-
loaded from the National Center for Biotechnology
Information Web database to our local computer. The
public Human Genome Project assembly confirms the
minimal tiling path and EST hits (Lander et al. 2001).
Gene prediction was carried out by GENSCAN (Burge
and Karlin 1997; GENSCANWeb server at MIT), FGE-
NES (Solovyev and Salamov 1997; Salamov and Solov-
yev 2000; CGGNucleotide Sequence AnalysisWeb site),
and MZEF (Zhang 1997; Gene Finder Web site).
Sequence Analysis
The 33 coding and noncoding exons of PCDH15were
PCR amplified from genomic DNA, using touchdown
PCR in a 20-ml reaction volume. Primers were designed
(using software at the Primer3 Web site) to flank the
exon-intron boundaries (see Appendix). PCR reactions
were performed with 50 ng genomic DNA in the pres-
ence of 5 pmol each of forward and reverse primers,
4.8% DMSO, 200 mM each dNTP, 0.75 M Betane,
1#PCR buffer (PE Biosystems), 1.5–2.5 mMMgCl2 (PE
Biosystems), and 0.5 U of a thermostable DNA poly-
merase. The thermal cycling conditions (PTC-225 DNA
Engine, MJ Research) were 95C for 2 min, 64C–69C
for 45 s, 72C for 45 s, and then nine cycles of touch-
down PCR, with annealing temperatures of 69C–54C,
followed by 35–38 cycles of annealing at 54C–60C,
and final extension at 72C for 15 min. Fifteen micro-
liters of this PCR product were then treated with 0.3 U
of shrimp alkaline phosphatase and 3 U of exonuclease
I at 37C for 1 h, followed by incubation at 80C for
15 min. This was diluted with an equal volume of dH2O,
and 6 ml was used for the final sequencing reaction. In
the sequencing reaction, we added 3.2 pmol of primer,
2 ml of Big Dye Terminator Ready Reaction Mix (PE
Biosystems), and 1 ml of 5# dilution buffer (400 mM
Tris-HCl pH 9 and 10 mM MgCl2). Cycling conditions
were 96C for 2 min and 45–49 cycles of 96C for 10
s, 55C for 10 s, and 60C for 4 min. Sequencing reaction
products were ethanol precipitated, and the pellets were
resuspended in 3 ml of formamide loading dye. An ABI
377 DNA sequencer was used to resolve the products,
and ABI prism software was used to analyze the results.
PHRED/PHRAP/CONSED/POLYPHRED software was
used for mutational analysis (Nickerson et al. 1997; Ew-
ing and Green 1998; Ewing et al. 1998; Gordon et al.
1998).
5′ RACE and cDNA Analysis
The genomic structure of PCDH15 was predicted on
the basis of “tblastn” homologies to Pcdh15 found in
the available human genomic DNA sequence. Fourteen
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Figure 1 Haplotypes of two Pakistani families demonstrating linkage to USH1F at 10q21-22. Two affected individuals, IV:13 and IV:14
in family PKSR17, provided the proximal recombination at marker D10S1643 (74.5 cM). The distal recombination is provided by unaffected
individual IV:2 of family PKSR8b, at marker D10S1226 (75.5 cM). Fundoscopic and ERG examination revealed early signs of retinitis pigmentosa
in affected members of both families. The genetic linkage distances are from the Center for Medical Genetics, Marshfield Medical Research
Foundation Web site (Broman et al. 1998).
primer pairs, designed from the predicted genomic
homology, were used to amplify the PCDH15 in over-
lapping segments from human brain Marathon-Ready
cDNA (Clontech). Primers from exon 9 (5′-GGAATAG-
AGGATTCCTGGCCTATCTG-3′), exon 8 (5′-TATGG-
CAGCTTGATAAGTGAGTGGAC-3′), exon 6 (5′-TCC-
ATTTGGTCCATCATCTATATCT-3′), exon 5 (5′-GT-
CATTCCTGTCTCTCACCACTATT-3′), exon 4 (5′-AT-
CAACACCCAGTAATCCACATTAT-3′), and exon 3
(5′-CGACTTTCTTCATCAATAGCAACTA-3′) were
used for a 5′ RACE PCR, using human brain Marathon-
Ready cDNA as template (Clontech). The thermal cy-
cling conditions used were 94C for 1 min, 25 cycles at
94C for 30 s, and 72C for 5 min. Five microliters of
each sample were analyzed on a 1.2% agarose/ethidium
bromide gel, were extracted with a QIAquick gel ex-
traction kit (Qiagen), and were cloned into Escherichia
coli through use of pGEM–T Easy Vector (Promega).
DNA was purified from minipreps using QIAquick
miniprep kit (Qiagen), and inserts were sequenced using
T7 and SP6 primers.
Northern Blot Analysis
Human donor eyes (ages 54 and 60 years) and human
occipital cortex (age 74 years) were obtained from the
National Disease Research Interchange. Total RNA was
isolated from dissected ocular tissues and brain, through
use of RNAzolB (Tel-Test). Ten micrograms each of total
RNA from retina, ciliary body, retinal pigmented epi-
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Table 1
Two-Point LOD Scores
MARKER
LOD SCORE (RECOMBINATION
FRACTION) FOR FAMILY
PKSR17 PKSR54a PKSR8b
D10S539 2.34 (.05) 2.73 (0) 1.05 (0)
D10S1643 2.64 (.05) 3.48 (0) .35 (0)
D10S1221 1.94 (0) 4.22 (0) 2.37 (0)
D10S1226 1.94 (0) 3.69 (0) 1.17 (.08)
D10S596 4.94 (0) 2.97 (0) .94 (0)
Figure 3 Domains of PCDH15, predicted from 1,955 amino acids. PCDH15 has a signal peptide at the amino terminus, 11 extracellular
calcium-binding domains, 1 predicted transmembrane domain, and a unique carboxy terminus (GenBank). TMpred and SMART predicted two
transmembrane domains (1054–1072 and 1376–1397), TMHMM predicted only one transmembrane domain, at 1376–1397 (SMART Web
site; TMHMM Server, version 2; TMpred Prediction of Transmembrane Regions and Orientation Server). The mutations found in two families
with USH1F are also annotated. RACE products obtained and three ESTs found in the NCBI nucleotide database are shown, along with the
590-bp probe used for the northern blot (fig. 5).
thelium (RPE)-choroid, iris, human brain (Clontech),
and human liver (Clontech), along with RNA size stan-
dards (Life Technologies), were electrophoresed on an
agarose-formaldehyde denaturing gel and were trans-
ferred to GeneScreen Plus membrane (Dupont-NEN).
RNA loading per lane was initially monitored using the
18S rRNA band (Correa-Rotter et al. 1992). The north-
ern blot was hybridized with a random primed, triple-
labeled ([a32P]-dATP, -dCTP, and -dGTP) 590-bp cDNA
probe, which had been PCR amplified through the use
of primers 5′-AGCAGAACTTGAAAAATCAGTAGC-3′
and 5′-CCTTATGTCTGTCATCTCCTACAATC-3′
from the unique carboxy-terminal domain of PCDH15.
The northern blot was hybridized at 63C in Hybrisol
II (Intergen) for 18 h and was washed at 63C in
0.2#SSC and 0.1% SDS.
Results
Family and Clinical Data
The disease phenotype in three Pakistani families dem-
onstrated linkage to STRP alleles in the reported USH1F
and DFNB23 interval (figs. 1 and 2). These consanguin-
eous families segregate autosomal recessive severe-to-
profound congenital deafness, determined by pure-tone
audiometry. Affected individuals from families PKSR17
and PKSR8b had frank signs of retinitis pigmentosa,
determined by fundoscopy or ERG examinations.
Family PKSR8b had three affected individuals for
whom polymorphic markers were found linked from
D10S1766 (69.7 cM) through D10S596 (75.6 cM), with
a LOD score of 2.37 (table 1). One individual with nor-
mal hearing, IV:2 (fig. 1), was homozygous for markers
D10S1226 (75.6 cM) and D10S596, providing the distal
recombination and further refining the linkage region.
Nine additional Usher loci (for types IA, 1B, 1C, 1D,
1E, IIA, IIB, IIC, and III) were excluded in this family
by genotype analysis of four STRPs at each locus (data
not shown).
Family PKSR17 had five affected individuals in two
sibships cosegregating retinitis pigmentosa and deafness.
Individuals IV:13 and IV:14 (figs. 1 and 2C) provided
the proximal recombination at marker D10S1642 (74.5
cM). Family PKSR54a had five affected individuals in
two sibships who were homozygous for seven markers
from D10S220 (70.23 cM) to D10S596 (75.6 cM). The
published distal recombination for USH1F is D10S596
(Wayne et al. 1997). LOD scores for all three families
are shown in table 1.
Identification of the USH1F Gene
The av mutation is a recessive allele associated with
deafness in the mouse (Schaible 1956). The genemutated
in av is Pcdh15 (Alagramam et al. 2001). Conserved
synteny between human andmouse chromosome 10 sug-
gested that Pcdh15may be the murine model forUSH1F
and/or DFNB23 (Alagramam et al. 2001). A protein-
sequence–similarity search indicated that the human or-
thologue of Pcdh15 spanned ∼1.6 Mb of genomic DNA
represented by 11 overlapping BACs on human 10q21.1.
There are three genes nested in the introns of PCDH15:
Ca2/calmodulin-dependent protein kinase type II, N-
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Figure 4 PCDH15 mutations in two Pakistani families. A, Se-
quence chromatograms for the splice-site mutation andwild-type allele
of family PKSR8b. An arrow (f) indicates the IVS272ArG replace-
ment in intron 27. The sequence trace file for the antisense strand is
shown. This transition mutation results in an alteration in the acceptor
splice site of exon 28. For genomic DNA with this mutation, GEN-
SCAN predicted the skipping of exon 28 and the use of an alternate
exon in intron 27. B, Sense strand–sequence chromatograms for
7CrT, found in family PKSR17, and for the wild-type allele. This
mutation results in a transition from an arginine to a termination
codon (R3X).
Figure 5 Northern blot for several human tissues. Lanes 1–6
contain 10 mg each of total RNA from human retina, ciliary body,
RPE-choroid, iris, brain, and liver. Positions of bands from an RNA
ladder are indicated along the right margin. A 6-d exposure to au-
toradiographic film is shown. In the retina, bands are apparent at∼3.3,
6.0, and 8.6 kb, with the larger transcript possibly being a doublet.
deacetylase/N-sulfotransferase (heparin glucosaminyl) 2
(NDST2), and plasminogen activator, urokinase (PLAU)
(fig. 2B). Only the first 2 of the 33 exons of PCDH15
are in the USH1F critical interval defined in family
PKSR17 (fig. 2B). Primer pairs from the predicted hu-
man PCDH15 exons, in combination with 5′ RACE,
allowed us to sequence PCDH15 from human brain
cDNA. The start codon is found in the middle of the
second exon, at 396 bp (GenBank). The stop codon is
in exon 33, at 6,263 bp, with additional downstream
termination codons in all three reading frames.PCDH15
encodes a predicted protein of 1,955 amino acids with
a molecular weight of ∼216 kD. The predicted protein
has 83% identity and 88% similarity with Pcdh15 (Al-
agramam et al. 2001). The sequence-analysis program
SMART predicted a protein (fig. 3) with a signal peptide
at the amino terminus, 11 extracellular calcium-binding
domains, a transmembrane domain, and a unique cyto-
plasmic domain in human protocadherin-15 (Schultz et
al. 2000; SMART Web site).
Sequence analysis of all the exons of PCDH15 (fig.
2B) in three Pakistani families revealed a splice-accep-
tor–site mutation (IVS272ArG) in intron 27 of family
PKSR8b (figs. 2B and 4). This mutation alters the in-
variant “A” of the acceptor splice site “AG” of exon
28, which encodes the 11th extracellular calcium-bind-
ing domain of protocadherin-15. This mutation was not
present among 240 chromosomes sequenced from 120
randomly selected unaffected control subjects of the
same ethnic group, nor was it found in 100 chromo-
somes from 50 control samples of the human diversity
panel (Coriell Cell Repositories). The GENSCAN pre-
dicted effect of IVS272ArG, when included in the oth-
erwise wild-type genomic sequence, is inclusion of a pu-
tative exon in intron 27 and skipping of exon 28. The
use of this predicted additional exonic sequence would
maintain an open reading frame with the replacement
of the previous 29 amino acids encoded by exon 28 with
33 incorrect amino acids. The predicted protein would
have 10 extracellular calcium-binding domains, rather
than 11.
In family PKSR17, only the first coding exon (exon
2) of PCDH15 is in the USH1F critical interval (fig. 2).
In exon 2 we found a substitution at nucleotide 7
(7CrT) resulting in the replacement of an arginine co-
don by a stop codon in the predicted signal peptide se-
quence of protocadherin-15 (R3X, figs. 3 and 4). If it is
assumed that there are no downstream cryptic transla-
tion-initiation codons, the predicted result of this non-
sense mutation is the complete loss of protocadherin-15
in the affected individuals of family PKSR17. This mu-
tation was not found in 580 chromosomes sequenced
from a total of 290 randomly selected unaffected control
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DNA samples from Pakistan and the Human Diversity
Panel. No other PCDH15 mutations were found in af-
fected individuals of family PKSR54a.
A northern blot was performed using a probe designed
from the unique cytoplasmic domain of PCDH15 (fig.
5). PCDH15 hybridizes to a major transcript from retina
at ∼3.3 kb, with additional lower-abundance transcripts
at ∼6.0 kb and ∼8.6 kb. These transcripts appear smaller
than those found in mouse brain. The longest PCDH15
open reading frame so far identified is 5.87 kb (fig. 3).
We also observed an ∼0.4-kb 5′ UTR and an ∼0.67-kb
3′ UTR. There are three ESTs found for PCDH15 in the
NCBI database (fig. 2), two from brain tissues and one
from placenta cDNA (fig. 3). In contrast, the five mouse
Pcdh15 ESTs in GenBank are all from retina cDNA.
Discussion
In affected individuals from two Pakistani families with
USH1F, we identified two mutant alleles of PCDH15,
demonstrating that PCDH15 function is necessary in the
sensory tissues of the human eye and ear. Affected mem-
bers of these two families with USH1F are profoundly
deaf at birth and show progressive retinopathy. In con-
trast to USH1F, the av mice have hearing loss but no
reported retinopathy. The av mice have a normal endo-
cochlear potential, ruling out the involvement of stria
vascularis, but the hair cells and supporting cells are
abnormal (Raphael et al. 2001). The av phenotype may
not be a good model for the retinopathy of USH1F, but
it may be a model for nonsyndromic recessive deafness
if mutant alleles of PCDH15 are found in affected mem-
bers of families linked to DFNB23. DFNB23 is listed
on the Hereditary Hearing Loss Homepage and may be
an allelic variant of PCDH15.
It is not unusual to observe phenotypic differences
between species carrying a mutation in the orthologous
gene; however, allelic differences can also underlie the
variation in phenotype (Libby and Steel 2001). Never-
theless, retinal pathology may be present in av mice.
The mouse model forUSH1B, sh1,was initially thought
to have a fully wild-type eye; however, an abnormal
accumulation of opsin occurs in the connecting cilium
of sh1 mice, and there is a failure of melanosome trans-
port to the apical processes in retinal epithelium (Liu
et al. 1998a, 1999; Liu andWilliams 2001). In addition,
a more sensitive evaluation revealed that five of nine
mutant Myo7a alleles cause a reduction in ERG am-
plitude with normal thresholds (Libby and Steel 2001).
There are six major subclassifications of the cadherin
superfamily, including protocadherins, almost all of
which are expressed in neuronal tissues (Nollet et al.
2000; Angst et al. 2001). A typical protocadherin will
have up to seven extracellular calcium-binding domains,
one transmembrane domain, and a unique intracellular
domain (Angst et al. 2001). There are 11 extracellular
calcium-binding domains predicted in the deduced
amino acid sequence of human and mouse brain
PCDH15 (fig. 3). On a northern blot containing human
RNA from several tissues, including brain, we find—in
addition to the expected full-length 7.0-kb PCDH15
message in human retina—a variety of putativePCDH15
transcripts, some of which are too small to contain all
11 calcium-binding domains, suggesting the possibility
of PCDH15 splice variants with various numbers of
predicted calcium-binding domains.
Examination of the regrowth patterns of neurons
after surgical intervention led to the idea that neurons
recognize their synaptic partners through “lock-and-
key” interactions between molecular “specifiers” dis-
played on neuronal surfaces (reviewed by Shapiro and
Colman [1999]). Cadherins—protocadherins in partic-
ular—are hypothesized to be part of the lock-and-key
molecular mechanism involved in synaptic sorting (re-
viewed by Shapiro and Colman [1999]). Some proto-
cadherin genes occur in clusters, which may allow the
generation of many isoforms, by rearrangement in a
manner similar to immunoglobulin genes (Shapiro and
Colman 1999; Wu and Maniatis 1999); however,
PCDH15 is not part of a protocadherin gene cluster on
10q21.1, and the stereocilia of both outer and inner
hair cells are abnormal in av mice. PCDH15 is hy-
pothesized to be involved in the development or main-
tenance of the stereocilia bundles on the apical surface
of hair cells (Alagramam et al. 2001).
In summary, we report that mutant PCDH15 alleles
are responsible for USH1F. We do not yet understand
the pathophysiology occurring in individuals with
USH1F or the normal function of the cadherin-like pro-
tein encoded by PCDH15. This knowledge would be
expected to form the keystone for the development of
a therapy.
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Appendix
Table A1
Primer Pairs for Sequencing the Exons of PCDH15
EXON
PRIMER
PRODUCT
LENGTH
(bp)Forward Reverse
1 ttgtcttttgggctgtagca tcatgacagagatcattgtactgaaa 612
2 ccagtgcattaaaccagtgtgt ggacatctgatttcacttttctaagc 452
3 attaattagattgcaagattttcctt tccatggatttgggttgaaa 300
4 gcagatactttggccttttgg gaaattgacaagcttccaggat 563
5 tgattgtcttctcttgtccttaaaa ttttcccatagttaaatgaattcctaa 518
6 cacttcagtttgtggttgtgg ccatcaaaaattagcttctagcaata 446
7 tcattctattttcagatgataagca ggtcaaagaatacagtgaataaaaaca 437
8 tgcctaatttctataaactacctgttg ccctgaaaataatttcggaca 367
9 tgctcccccttaacattcaa ttgaattgctttgcttcttcc 520
10 gtctgctttccctgaactgc tgggcttcgcttattttctt 418
11 gcctcactggattttcatttc ctttttaaaatatccttgttttgga 551
12 ttccacgatataggtcaccatc ttcttctgtgaggaagaatgttaat 557
13 tgcttcttaccatattagaacactttt tgcttttatttgaaaagtaacagaaat 515
14 ttgtgattgctttagtattgtaacgg tgcctctgatattgtccttttc 587
15 tcctgtaaacccaacaactgaata atccatattacccttgctttcctt 371
16 tttccacatcaggtaggattaca aaaatgttaaaaataaacagtctcctg 487
17 gccttaaaagctgttttcaatttt aaggttgcagcacaatagca 471
18 cagatagacaaatgccagaatga aaatgtaaatctgtatccttgaaagtt 408
19 tcctccttagagggccaaat cacaaaccctaatagcaaatctcc 495
20 gcactaacgcatgacttcca tgttatgggtctggtaccactg 437
21 tgaggtgccagtctgaaatg tgcattctagaaaaacaaaaagca 500
22 tgatctggctacatttcagctc tccaagatgtgagataccaagtg 488
23 ccttctggaaccaggcaat cgcctaaaccaaaattggaa 337
24 cctgcagacctcctccagta tcactttagctaacatcactggattt 302
25 caaaagccagcattttgtca atcactccctgccttgtcat 465
26 ggcatggcatctagaaatgg aaaatgaaactcaagaagttgct 463
27 cagacatttaggagggcttt agtgactaacaatctgagtgaaaa 520
28 gaatttgaaaatcagaaaccactg cagttaaaaatcatggtcatataaaaa 267
29 tgggagctaaatgctgaaaaa cctgaaaactttaaggcatgaga 532
30 tgaattctaccccttattcaagaga tcagagttcctgaacggtctactta 417
31 caagccatccttactttatccaa tgcaattgtctcctgaagttg 428
32 tgtcattaactctgtcattatgaattt aaactattacaaacgcaaaacaagg 270
33a catttctcattcttctcacaactc cctcctgggtaagctgactg 595
33b ttcagacatttcacagagaacaga gagagtgaagaatgtaaaacacaagg 522
33c caagaactgtggaactcaaatcag cctgttatacagacacactctgtgg 502
33d ctacctccatttccaactcctct atttcattgaatttggggtaaaat 553
33e gcaaacctcttgttgatcatagtc ccaaatacataggcttcaagaaaaa 444
33f tgtggatgcagtaacatttacatt aaatgccttacaaaagtcaacgac 446
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